CAS 1062161-90-3

WYE-687

Description:

WYE-687, with the CAS number 1062161-90-3, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a selective inhibitor of certain enzymes, specifically those involved in the modulation of inflammatory pathways. This compound exhibits properties that may contribute to its efficacy in treating conditions related to inflammation and autoimmune disorders. WYE-687 is characterized by its specific molecular structure, which facilitates its interaction with target proteins, thereby influencing biological processes. The compound has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are crucial for understanding its behavior in biological systems. Additionally, its safety profile and potential side effects are important considerations in the context of drug development. Overall, WYE-687 represents a promising candidate in the realm of medicinal chemistry, with ongoing research aimed at elucidating its full therapeutic potential and mechanisms of action.

WYE-687

CAS: 1062161-90-3

WYE-687

Purity: ≥98%

Molecular weight: 528.61g/mol

Ref: 54-BUP06771

WYE-687

CAS: 1062161-90-3

WYE-687 is a selective mTOR inhibitor (IC50: 7 nM), over 100x more selective for mTOR than PI3Kα/γ, affecting mTORC1/pS6K and mTORC2/P-AKT(S473).

Formula: C₂₈H₃₂N₈O₃

Purity: 99.93%

Color and Shape: Solid

Molecular weight: 528.61

Ref: TM-T6732

WYE-687

Controlled Product

CAS: 1062161-90-3

Formula: C₂₈H₃₂N₈O₃

Color and Shape: Neat

Molecular weight: 528.606

Ref: TR-W950005

WYE-687

CAS: 1062161-90-3

WYE-687 is a novel small molecule that inhibits lipid kinase activity and is able to induce senescence in cells. It has potent antitumor activity against cancer cells and potently inhibits the growth of xenograft tumors in mice. WYE-687 also possesses potential as a drug target for autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. The drug has been shown to inhibit angiogenesis, which is the formation of new blood vessels from pre-existing ones, both in vitro and in vivo. WYE-687 has been shown to be well tolerated by animals after oral administration, with no observable side effects.

Formula: C₂₈H₃₂N₈O₃

Purity: Min. 95%

Molecular weight: 528.61 g/mol

Ref: 3D-MSB16190